Venolife gel d / nar. approx. 0.25% + 5% + 2% tube 100g

Amount in a package

100 g

Dosage form

gel for external use

Manufacturer

Akrikhin, Russia

Structure

Active ingredients: troxerutin 2g

dexpanthenol 5 g

sodium heparin 0.25 g (30,000 IU)

Excipients: phenylethyl alcohol, propylene glycol, carbomer 940 or 980, trometamol, purified water.

pharmachologic effect

Venolife is a combined preparation for external use.

Dexpanthenol, a provitamin B5, is converted in the skin into pantothenic acid, which is a part of coenzyme A, which plays an important role in the processes of acetylation and oxidation.

Improving metabolic processes, dexpanthenol promotes the regeneration of damaged tissues

improves the absorption of heparin.

Heparin is a direct anticoagulant, a natural anticoagulant factor in the body.

It has an anti-inflammatory effect, promotes the regeneration of connective tissue by inhibiting the activity of hyaluronidase

prevents thrombus formation, activates the fibrinolytic properties of blood, improves local blood flow.

Troxerutin is an angioprotective agent.

It has P-vitamin activity, in particular, it reduces vascular tissue permeability and capillary fragility, contributes to the normalization of microcirculation and tissue trophism, reduces congestion in veins and paravenous tissues, and has anti-edema and anti-inflammatory effects.

In addition, due to the presence of an antiseptic preservative, phenylethyl alcohol, the drug has a bactericidal and fungicidal effect, helping to prevent infection of the wound surface.

The composition of the gel base provides the drug with moderate hyperosmolar properties.

Indications

Soft tissue injuries (hematomas, dislocations, sprains)

edematous pain syndrome and microcirculatory-trophic disorders caused by venous insufficiency of the lower extremities (varicose veins, acute and chronic thrombophlebitis, post-thrombophlebitic syndrome, chronic lymphostasis)

to accelerate the granulation and epithelization of trophic ulcers in the regeneration phase (in the absence of pronounced exudation).

Application during pregnancy and lactation

Venolife® is not contraindicated during pregnancy and lactation.

Contraindications

Hypersensitivity, open, infected wounds or wounds with profuse exudation.

Side effects

Local manifestations of allergic reactions (skin rash, itching) are possible.

How to take, course of administration and dosage

Locally.

Apply in a thin layer to the affected area and around it 2-3 times a day, evenly spreading over the skin surface with light rubbing movements until completely absorbed.

The course of treatment is 2-3 weeks.

The need for further treatment is determined by the attending physician, based on the severity of the pathological process and the results of clinical tests.

In case of recurrence of the disease, the course of treatment can be carried out 2-3 times a year.

In case of trophic ulcers with weak exudation, before using the drug, the wound surface is cleaned of exudate and necrotic tissues, if necessary, washed with a solution of hydrogen peroxide 3%, furacilin 1: 5000 or chlorhexidine bigluconate 0.05% and dried.

The gel is applied in a uniform thin layer so that the entire affected surface is covered with the preparation, and a sterile gauze bandage is applied.

Dressings are changed once a day.

With an open method of treatment, the drug is applied 1–2 times a day.

The duration of treatment is determined by the dynamics of epithelialization.

Special instructions

Venolife is not intended for use in ophthalmology, for intravaginal and rectal administration.

Release form

Gel for external use

Storage conditions

At a temperature of 15-25 ° C

Shelf life

2 years

Active substance

Heparin sodium, Dexpanthenol, Troxerutin

Terms of dispensing from pharmacies

Without recipe

Name ENG

VENOLIFE

Clinical and pharmacological group

The drug with antithrombotic, angioprotective, venotonic and improving tissue regeneration action for external use

ATX code

Heparin in combination with other drugs

Dosage

0.25% + 5% + 2% x 100g

Structure

Active ingredients: troxerutin 2g

dexpanthenol 5 g

sodium heparin 0.25 g (30,000 IU)

Excipients: phenylethyl alcohol, propylene glycol, carbomer 940 or 980, trometamol, purified water.

Indications

Edematous pain syndrome and microcirculatory-trophic disorders caused by venous insufficiency of the lower extremities (varicose veins, acute and chronic thrombophlebitis, post-thrombophlebitic syndrome, chronic lymphostasis)

soft tissue injuries (hematomas, dislocations, sprains)

to accelerate the granulation and epithelization of trophic ulcers in the regeneration phase (in the absence of pronounced exudation).

Contraindications

Hypersensitivity to Venolife components, open infected wounds or wounds with profuse exudation.

Storage conditions and periods

At a temperature of 15-25 degrees.

Expiration date: 2 years

INN / Active ingredient

troxerutin, dexpanthenol, sodium heparin

Specifications

Scope of the drug

Heart, vessels, blood

Release form

Gel

Manufacturer country

Russia

Package quantity, pcs

one

Way of introduction

On the skin

Vacation conditions

Without recipe

Brand name

Akrikhin

The amount of the dosage form in the primary package

100 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

C05BA53 Heparin sodium, in combination with other drugs

Dosage form

Gel for external use

Expiration date in days

730

Package weight, g

45

Category

:

Improving blood circulation

,

Angioprotectors and microcirculation correctors

,

Lipid-lowering drugs

,

Hematopoietic stimulants

Mode of application

:

The drug is used externally. < br> < br> The gel is applied in a thin layer to the affected area 2-3 times / day, evenly spreading over the skin surface with light rubbing movements until completely absorbed. The course of treatment is 2-3 weeks. The need for further treatment is determined by the attending physician, based on the severity of the pathological process and the results of clinical tests. < br> < br> In case of relapse of the disease, the course of treatment can be carried out 2-3 times a year. < br> < br> In trophic ulcers with weak exudation before using the drug, the wound surface is cleaned of exudate and necrotic tissues, if necessary, washed with 3% hydrogen peroxide solution, furacilin solution 1: 5000 or 0.05% chlorhexidine bigluconate solution and dried. The gel is applied in an even thin layer so thatso that the entire affected surface is covered with the drug, and a sterile gauze bandage is applied. Dressings are changed once a day. With an open method of treatment, the drug is applied 1-2 times / day. The duration of treatment is determined by the dynamics of epithelialization.

Pharmaco-therapeutic group

:

Direct-acting anticoagulant for topical use + other drugs

Dosage (volume) of the substance in the preparation

:

sodium heparin in terms of dry matter 0.25 g (30,000 IU) < IR> dexpanthenol in terms of 100% substance 5 g < IR> troxerutin in terms of 100% substance 2 g

Information on technical characteristics, delivery set, country of manufacture